Trademark: 97169691
Word
BREDORSE
Status
Registered
Status Code
700
Status Date
Tuesday, January 17, 2023
Serial Number
97169691
Registration Number
6953594
Registration Date
Tuesday, January 17, 2023
Mark Type
4000
Filing Date
Monday, December 13, 2021
Published for Opposition
Tuesday, November 1, 2022

Trademark Owner History
Glaxo Group Limited - Original Registrant

Classifications
5 Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Trademark Events
Jun 29, 2023
Teas Change Of Correspondence Received
Jun 29, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 29, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jun 29, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Jun 29, 2023
Teas Change Of Owner Address Received
Jan 17, 2023
Notice Of Registration Confirmation Emailed
Jan 17, 2023
Registered-Principal Register
Nov 9, 2022
Teas Change Of Correspondence Received
Nov 9, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 9, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 1, 2022
Official Gazette Publication Confirmation E-Mailed
Nov 1, 2022
Published For Opposition
Oct 12, 2022
Notification Of Notice Of Publication E-Mailed
Sep 26, 2022
Approved For Pub - Principal Register
Sep 20, 2022
Assigned To Examiner
Dec 17, 2021
New Application Office Supplied Data Entered
Dec 16, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24